Pepcid and Heavy or prolong menstrual bleeding - a phase IV clinical study of FDA data

Summary:

Heavy or prolong menstrual bleeding is reported as a side effect among people who take Pepcid (famotidine), especially for people who are 30-39 old, have been taking the drug for < 1 month also take Zofran, and have Metastases to bone.

The phase IV clinical study analyzes which people have Heavy or prolong menstrual bleeding when taking Pepcid. It is created by eHealthMe based on reports of 54,527 people who have side effects when taking Pepcid from the FDA, and is updated regularly.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

What is Heavy or prolong menstrual bleeding?

Heavy or prolong menstrual bleeding is found to be associated with 746 drugs and 1,264 conditions by eHealthMe. Check the latest studies of Heavy or prolong menstrual bleeding.

On Aug, 02, 2026

54,527 people reported to have side effects when taking Pepcid.
Among them, 65 people (0.12%) have Heavy or prolong menstrual bleeding.

Could Pepcid cause Heavy or prolong menstrual bleeding?

Among these 65 people:

How long have people been on Pepcid when they have Heavy or prolong menstrual bleeding? *

What is the age of people who have Heavy or prolong menstrual bleeding when taking Pepcid? *

What are other drugs people take besides Pepcid? *

What are other side effects people have besides Heavy or prolong menstrual bleeding? *

Pain: 26 people, 40.00%
Nausea (feeling of having an urge to vomit): 25 people, 38.46%
Abdominal Pain: 24 people, 36.92%
Urinary Tract Infection: 22 people, 33.85%
Diarrhea: 22 people, 33.85%
Anaemia (lack of blood): 21 people, 32.31%
Fatigue (feeling of tiredness): 20 people, 30.77%
Chest Pain: 19 people, 29.23%
Stress And Anxiety: 19 people, 29.23%
Back Pain: 17 people, 26.15%

What are the existing conditions these people have? *

Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 13 people, 20.00%
Metastases To Bone (cancer spreads to bone): 13 people, 20.00%
Pain: 10 people, 15.38%
Breast Cancer: 10 people, 15.38%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 12.31%
Birth Control: 7 people, 10.77%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 9.23%
Depression: 4 people, 6.15%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 4.62%
Insomnia (sleeplessness): 3 people, 4.62%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid and have Heavy or prolong menstrual bleeding?

- Check whether Heavy or prolong menstrual bleeding is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pepcid:

Pepcid (55,774 reports)

Browse all side effects of Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heavy or prolong menstrual bleeding:

Heavy or prolong menstrual bleeding (746 drugs)

Browse all the conditions that are associated with Heavy or prolong menstrual bleeding:

Heavy or prolong menstrual bleeding (1,264 conditions)

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on famotidine (the active ingredients of Pepcid) and Pepcid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.